Vulnerability in Clinical Research with Patients in Pain: A Risk Analysis

U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Guidelines for the Protection of Human Subjects of Research (Washington, D.C.: U.S. Government Printing Office, 1979): at 8.

Council for International Organization of Medical Societies, International Ethical Guidelines for Biomedical Research involving Human Subjects, Commentary on Guideline 13, 2002, available at <www.cioms.ch> (last visited July 15, 2008).

DeBruin D. , “Reflections on “Vulnerability,” Bioethics Examiner 5, no. 3 (2001): 1–7; Levine C. Faden R. Grady C. Hammerschmidt D. Eckenwiler L. Sugarman J. , “The Limitations of ‘Vulnerability’ as a Protection for Human Research Subjects,” American Journal of Bioethics 4, no. 3 (2004): 44–49.

Grinnell F. , “Subject Vulnerability: The Precautionary Principle of Human Research,” American Journal of Bioethics 4, no. 3 (2004): 72–74; see Levine , supra note 3.

Kottow M. H. , “The Vulnerable and the Susceptible,” Bioethics 17, nos. 5–6 (2003): 460–471; see also Levine , supra note 3.

Schweitzer A. , On the Edge of the Primeval Forest (New York: Macmillan, 1931): at 2.

Blacksher E. , “Hearing from Pain: Using Ethics to Reframe, Prevent, and Resolve the Problem of Unrelieved Pain,” Pain Medicine 2, no. 2 (2001): 169–175.

Brennan F. Carr D. B. Cousins M. , “Pain Management: A Fundamental Right,” Anesthesia & Analgesia 105, no. 1 (2007): 205–221.

VanderWalde A. M. , “Vulnerability as the Inability of Researchers to Act in the Best Interest of a Subject,” American Journal of Bioethics 4, no. 3 (2004): 65–66.

Henderson G. E. Davis A. M. King N. M. P. , “Vulnerability to Influence: A Two-Way Street,” American Journal of Bioethics 4, no. 3 (2004): 50–52.

Shivas T. , “Contextualizing the Vulnerability Standard,” American Journal of Bioethics 4, no. 3 (2004): 84–86.

Marshall M. F. , “Vulnerable Subjects and Civic Professionalism: Would Six-Sigma Research and Research Ethics Consultation Solve the Vulnerability Problem?” American Journal of Bioethics 4, no. 3 (2004): 54–55.

Vawter D. E. Gervais K. G. Freeman T. B. , “Strategies for Achieving High-Quality IRB Review,” American Journal of Bioethics 4, no. 3 (2004): 74–76.

Campbell A. T. , “‘Vulnerability’ in Context: Recognizing the Sociopolitical Influences,” American Journal of Bioethics 4, no. 3 (2004): 58–59.

Healy D. Cattel D. , “Interface between Authorship, Industry and Science in the Domain of Therapeutics,” British Journal of Psychiatry 183, nos. 3–4 (2003): 22–27; Psaty B. M. Kronmal R. A. , “Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment,” JAMA 299, no. 15 (2008): 1813–1817.

Lemmens T. Miller P. B. , “The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives,” Journal of Law, Medicine & Ethics 31, no. 3 (2003): 398–418.

DeAngelis C. D. Fontanarosa P. B. , “Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence,” JAMA 299, no. 15 (2008): 1833–1835; Ross J. S. Hill K. P. Egilman D. S. Krumholz H. M. , “Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation,” JAMA 299, no. 15 (2008): 1800–1812.

DeBruin D. A. , “Looking Beyond the Limitations of ‘Vulnerability’: Reforming Safeguards in Research,” American Journal of Bioethics 4, no. 3 (2004): 76–78.

See DeBruin , supra note 3, at 7.

Merskey H. Bogduk N. , Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed. (Seattle: IASP Press, 1994): at 210.

Turk D. C. Melzack R. , “The Measurement of Pain and the Assessment of People Experiencing Pain,” in Turk D. C. Melzack R. , eds., Handbook of Pain Assessment, 2nd ed. (New York: The Guilford Press, 2001): at 3.

Jensen R. Tfelt-Hansen P. , “Headache,” in Jensen T. S. Wilson P. R. Rice A. S. C. , eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): at 467.

Campbell F. A. Atcheson R. , “Chronic Back Pain,” in Jensen T. S. Wilson P. R. Rice A. S. C. , eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): at 524.

Turner J. A. LeResche L. Von Korff M. Ehrlich K. , “Back Pain in Primary Care: Patient Characteristics, Content of Initial Visit, and Short-Term Outcomes,” Spine 23, no. 4 (1998): 463–469; Turner J. A. Franklin G. Turk D. C. , “Predictors of Chronic Disability in Injured Workers: A Systematic Literature Synthesis,” American Journal of Industrial Medicine 38, no. 6 (2000): 707–722; Gatchel R. J. Dersh J. , “Psychological Disorders and Chronic Pain: Are There Cause- and-Effect Relationships?” in Turk D. C. Gatchel R. J. , eds., Psychological Approaches to Pain Management: A Practitioner's Handbook, 2nd ed. (London: The Guilford Press, 2002): at 33.

Merskey H. Teasell R. W. , “The Disparagement of Pain: Social Influences on Medical Thinking,” Pain Research and Management 5, no. 4 (2000): 259–270.

Agrawal M. Emanuel E. J. , “Ethics of Phase 1 Oncology Studies: Reexamining the Arguments and Data,” JAMA 290, no. 8 (2003): 1075–1082; Cantor N. L. Thomas G. C. , “Pain Relief, Acceleration of Death, and Criminal Law,” Kennedy Institute of Ethics Journal 6, no. 2 (1996): 107–128; Emanuel E. J. , “Pain and Symptom Control: Patient Rights and Physician Responsibilities,” Hematology/Oncology Clinics of North America 10, no. 1 (1996): 41–56; Emanuel E. J. , “Attending to Psychologic Symptoms and Palliative Care,” Journal of Clinical Oncology 20 (2002): 624–626; Pellegrino E. D. , “Emerging Ethical Issues in Palliative Care,” JAMA 279, no. 19 (1998): 1521–1522.

Hadler N. M. , “MRI for Regional Back Pain: Need for Less Imaging, Better Understanding,” JAMA 289, no. 21 (2003): 2863–2865; Rudy T. E. Turk D. C. Brena S. F. , “Differential Utility of Medical Procedures in the Assessment of Chronic Pain Patients,” Pain 34, no. 1 (1988): 53–60.

Chibnall J. T. Tait R. C. Ross L. R. , “The Effects of Medical Evidence and Pain Intensity on Medical Student Judgments of Chronic Pain Patients,” Journal of Behavioral Medicine 20, no. 3 (1997): 257–271; Grossman S. A. Sheidler V. R. Swedeen K. Mucenski J. Piantadosi S. , “Correlation of Patient and Caregiver Ratings of Cancer Pain,” Journal of Pain and Symptom Management 6, no. 2 (1991): 53–57.

Tait R. C. Chibnall J. T. Kalauokalani D. A. , “Provider Judgments of Patients in Pain: Seeking Symptom Certainty,” Pain Medicine (in press).

Fiske S. T. Taylor S. E. , Social Cognition, 2nd ed. (New York: McGraw-Hill, 1991): at 14.

See Brennan , supra note 8; Cassell E. J. , “The Nature of Suffering and the Goals of Medicine,” New England Journal of Medicine 306, no. 11 (1982): 639–645; Rich B. A. , “A Legacy of Silence: Bioethics and the Culture of Pain,” Journal of Medical Humanities 18, no. 4 (1997): 233–259; Johnson S. H. , “Legal and Ethical Perspectives on Pain Management,” Anesthesia & Analgesia 105, no. 1 (2007): 5–7; Merskey Teasell , supra note 25.

Tait R. C. , “The Social Context of Pain Management,” Pain Medicine 8, no. 1 (2007): 1–2.

Blacksher E. , “Hearing from Pain: Using Ethics to Reframe, Prevent, and Resolve the Problem of Unrelieved Pain,” Pain Medicine 2, no. 2 (2001): 169–175, at 170.

Appelbaum P. S. Lidz C. W. Grisso T. , “Therapeutic Misconception in Clinical Research: Frequency and Risk Factors,” IRB: Ethics & Human Research 26, no. 2 (2004): 1–8, at 1.

Fleming S. Rabago D. P. Mundt M. P. Fleming M. F. , “CAM Therapies among Primary Care Patients Using Opioid Therapy for Chronic Pain,” BMC Complementary and Alternative Medicine 7, no. 15 (2007): 15–22, available at <http://www.biomedcentral.com/1472–6882> (last visited July 15, 2008); Upchurch D. M. Chyu L. Greendale G. A. Utts J. Bair Y. A. Zhang G. Gold E. B. , “Complementary and Alternative Medicine Use among American Women: Findings from the National Health Interview Survey, 2002,” Journal of Women's Health 16, no. 1 (2007): 102–113.

Werner A. Malterud K. , “It Is Hard Work Behaving as a Credible Patient: Encounters between Women with Chronic Pain and Their Doctors,” Social Science & Medicine 57, no. 8 (2003): 1409–1419.

Camarda C. Monastero R. Pipia C. Reca D. Camarda R. , “Interictal Executive Dysfunction in Migraineurs without Aura: Relationship with Duration and Intensity of Attacks,” Cephalalgia 27, no. 10 (2007): 1094–1100; Dick B. D. Rashiq S. , “Disruption of Attention and Working Memory Traces in Individuals with Chronic Pain,” Anesthesia & Analgesia 104, no. 5 (2007): 1223–1239.

Dick B. D. Eccleston C. Crombez G. , “Attentional Functioning in Fibromyalgia, Rheumatoid Arthritis, and Musculoskeletal Pain Patients,” Arthritis & Rheumatism 47, no. 6 (2002): 639–644.

Bayer A. Fish M. , “The Doctor's Duty to the Elderly Patient in Clinical Trials,” Drugs & Aging 20, no. 15 (2003): 1087–1097; Dick B. , “Fitness of Patients in Pain to Make Optimal Decisions,” Anesthesia & Analgesia 106, no. 2 (2008): 669–670.

Kim S. Y. H. Caine E. D. Currier G. W. Leibovici A. Ryan J. M. , “Assessing the Competence of Persons with Alzheimer's Disease in Providing Informed Consent for Participation in Research,” American Journal of Psychiatry 158, no. 5 (2001): 712–717; Raymont V. Bingley W. Buchanan A. David A. S. Hayward P. Wessely S. Hotopf M. , “Prevalence of Mental Incapacity in Medical Inpatients and Associated Risk Factors: Cross-sectional Study,” The Lancet 364, no. 9443 (2004): 1421–1427.

See Gatchel Dersh , supra note 24; Sullivan M. D. , “Assessment of Psychiatric Disorders,” in Turk D. C. Melzack R. , eds., Handbook of Pain Assessment, 2nd ed. (New York: The Guilford Press, 2001): 275–291, at 275.

Dresser J. D. , “Research Involving Persons with Mental Disabilities: A Review of Policy Issues and Proposals,” in National Bioethics Advisory Commission, Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity: Commissioned Papers, 1999, at 5–28.

Appelbaum P. S. Grisso T. Frank E. O'Donnell S. Kupfer D. J. , “Competence of Depressed Patients for Consent to Research,” American Journal of Psychiatry 156, no. 9 (1999): 1380–1384.

Roberts L. W. , “Ethics and Mental Illness Research,” Psychiatric Clinics of North America 25, no. 3 (2002): 525–545.

Chen D. T. Miller F. G. Rosenstein D. L. , “Enrolling Decisionally Impaired Adults in Clinical Research,” Medical Care 40, Supplement 9 (2002): V20–V29; Wirshing D. A. Wirshing W. C. Marder S. R. Liberman R. P. Mintz J. , “Informed Consent: Assessment of Comprehension,” American Journal of Psychiatry 155, no. 9, Supplement (1998): 1508–1511.

See Turner (1998), supra note 24.

Deshields T. L. Tait R. C. Gfeller J. Chibnall J. T. , “The Influence of Social Desirability on Self-Report in Chronic Pain Patients,” Clinical Journal of Pain 11, no. 3 (1995): 189–193.

Williams D. A. Park K. M. Ambrose K. R. Clauw D. J. , “Assessor Status Influences Pain Recall,” Journal of Pain 8, no. 4 (2007): 343–348.

Jones K. R. Fink R. M. Clark L. Hutt E. Vojir C. P. Mellis B. K. , “Nursing Home Resident Barriers to Effective Pain Management: Why Nursing Home Residents May Not Seek Pain Medication,” Journal of the American Medical Directors Association 6, no. 1 (2005): 10–17; Ward S. Goldberg N. Miller-McCauley V. Mueller C. Nolan A. Pawlik-Plank D. Robbins A. Stormoen D. Weissman D. E. , “Patient-Related Barriers to Management of Cancer Pain,” Pain 52, no. 3 (1993): 319–324.

Tait R. C. Chibnall J. T. , “Observer Perceptions of Chronic Low Back Pain,” Journal of Applied Social Psychology 24, no. 5 (1994): 415–431.

Nurmikko T. J. , “Anticonvulsants and Antiarrhythmics,” in Jensen T. S. Wilson P. R. Rice A. S. C. , eds., Chronic Pain: Clinical Pain Management (London: Arnold Publishers, 2003): 251–260, at 252.

Martell B. A. O'Connor P. G. Kerns R. D. Becker W. C. Morales K. H. Kosten T. R. Fiellin D. A. , “Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction,” Annals of Internal Medicine 146, no. 2 (2007): 116–127.

Fanciullo G. J. Ball P. A. Girault G. Rose R. J. Hanscom B. Weinstein J. N. , “An Observational Study on the Prevalence and Pattern of Opioid Use in 25,479 Patients with Spine and Radicular Pain,” Spine 27, no. 2 (2002): 201–205, at 201; Rich B. A. , “Ethics of Opioid Analgesia for Chronic Noncancer Pain,” Pain: Clinical Updates 15, no. 9 (2007): 1–4.

Webster L. R. Fakata K. L. Charapata S. Fisher R. MineHart M. , “Open-Label, Multicenter Study of Combined Intrathecal Morphine and Ziconitide: Addition of Morphine in Patients Receiving Ziconitide for Severe Chronic Pain,” Pain Medicine 9, no. 3 (2008): 282–290.

Rog D. J. Nurmikko T. J. Friede T. Young C. A. , “Randomized, Controlled Trial of Cannabis-based Medicine in Central Pain in Multiple Sclerosis,” Neurology 65, no. 6 (2005): 812–819; Ware M. A. Doyle C. R. Woods R. Lynch M. E. Clark A. J. , “Cannabis Use for Chronic Non-cancer Pain: Results of a Prospective Survey,” Pain 102, nos. 1–2 (2003): 211–216; Wilsey B. Marcotte T. Tsodikov A. Millman J. Bentley H. Gouaux B. Fishman S. , “A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain,” Journal of Pain 9, no. 6 (2008): 506–521.

See Henderson , supra note 10.

Dresser R. , “The Ubiquity and Utility of the Therapeutic Misconception,” Social Philosophy and Policy 19, no. 2 (2002): 271–294.

See Tait , supra note 29.

See Tait Chibnall , supra note 51.

See Chibnall , supra note 28.

Wazana A. , “Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?” JAMA 283, no. 3 (2000): 373–380; Steinbrook R. , “Financial Support of Continuing Medical Education,” JAMA 299, no. 9 (2008): 1060–1062.

Choudhry N. K. Stelfox H. T. Detsky A. S. , “Relationships between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry,” JAMA 287, no. 5 (2002): 612–617.

Lemmons T. Miller P. B. , “The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives,” Journal of Law, Medicine & Ethics 31, no. 3 (2003): 398–418.

See Ross , supra note 17.

See Chibnall , supra note 28.

Beneke M. Rasmus W. , “Clinical Global Impressions (ECDEU): Some Critical Comments,” Pharmacopsychiatry 25, no. 4 (1992): 171–176.

See Chibnall , supra note 28.

Rothman K. J. Michels K. B. , “The Continuing Unethical Use of Placebo Controls,” New England Journal of Medicine 331, no. 6 (1994): 394–398; Khan A. Warner H. A. Brown W. A. , “Symptom Reduction and Suicide Risk in Patients Treated with Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database,” Archives of General Psychiatry 57, no. 4 (2000): 311–317.

McQuay H. J. Moore R. A. , “Placebo,” Postgraduate Medical Journal 81, no. 953 (2005): 155–160; Temple R. Ellenberg S. S. , “Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments,” Annals of Internal Medicine 133, no. 6 (2000): 455–463.

Dworkin R. H. Katz J. Gitlin M. J. , “Placebo Response in Clinical Trials of Depression and Its Implications for Research on Chronic Neuropathic Pain,” Neurology 65, no. 12, Supplement 4 (2005): S7–S19; Nagasako E. M. Kalauokalani D. A. , “Ethical Aspects of Placebo Groups in Pain Trials,” Neurology 65, no. 12, Supplement 4 (2005): S59–S65.

See McQuay Moore , supra note 70; Temple Ellenberg , supra note 70; Nagasako Kalauokalani , supra note 71.

See Dworkin , supra note 71.

Erdal K. J. Zautra A. J. , “Psychological Impact of Illness Downturns: A Comparison of New and Chronic Conditions,” Psychology and Aging 10, no. 4 (1995): 570–575.

Luebbert R. Tait R. C. Chibnall J. T. Deshields T. L. , “IRB member Judgments of Decisional Capacity, Coercion, and Risk in Medical and Psychiatric Studies,” Journal of Empirical Research in Human Research Ethics 3, no. 1 (2008): 15–24.

See Rich , supra notes 31 and 54; Tait R. C. Miller L. , “The Multidisciplinary Treatment of Pain in Vulnerable Populations,” in Schatman M. E. Campbell A. , eds., Chronic Pain Management: A Guidebook for Multidisciplinary Program Development (New York: Informa Healthcare, 2008): 129–150, at 129.

Sharpe M. Mayou R. Seagroatt V. Surawy C. Warwick H. , “Why Do Doctors Find Some Patients Difficult to Help?” Quarterly Journal of Medicine 87, no. 3 (1994): 187–193.

Gevirtz C. , “Imbalance and Inconsistency Continue in DEA Policy on Medical Use of Opioids,” Topics in Pain Management: Current Concepts and Treatment Strategies 21, no. 10 (2006): 6–7; see Rich , supra note 54.

See Brennan , supra note 8; Fishman S. M. , “Risk of the View through the Keyhole: There Is Much More to Physician Reactions to the DEA Than the Number of Formal Actions,” Pain Medicine 7, no. 4 (2006): 360–362; Jung B. Reidenberg M. M. , “The Risk of Action by the Drug Enforcement Administration against Physicians Prescribing Opioids for Pain,” Pain Medicine 7, no. 4 (2006): 353–357.

Lin J. J. Alfandre D. Moore C. , “Physician Attitudes toward Opioid Prescribing for Patients with Persistent Non-cancer Pain,” Clinical Journal of Pain 23, no. 9 (2007): 799–803, at 802.

See Brennan , supra note 8; see Rich , supra note 31.

Grisso T. Appelbaum P. S. Mulvey E. P. Fletcher K. , “The MacArthur Treatment Competence Study, II: Measures of Abilities Related to Competence to Consent to Treatment,” Law and Human Behavior 19, no. 2 (1995): 127–148.

See Luebbert , supra note 75.

Redelmeier D. A. Koehler D. J. Liberman V. Tversky A. , “Probability Judgment in Medicine: Discounting Unspecified Possibilities,” Medical Decision Making 15, no. 3 (1995): 227–230.

See Brennan , supra note 8.